Arcus Biosciences, Inc. (RCUS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Arcus Biosciences, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -7.25x | -4.74x | -4.60x | -5.58x | 52.95x | -11.56x |
| P/B Ratio | 4.06x | 2.77x | 3.06x | 2.27x | 3.34x | 2.83x |
| P/S Ratio | 10.36x | 5.20x | 12.08x | 13.29x | 7.33x | 18.23x |
| Profitability | ||||||
| Gross Margin | 96.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -156.3% | -127.9% | -290.6% | -250.0% | 14.1% | -159.0% |
| Net Margin | -142.9% | -109.7% | -262.4% | -238.4% | 13.8% | -157.7% |
| EBITDA Margin | -135.6% | -104.3% | -248.7% | -230.4% | 15.4% | -153.8% |
| Liquidity | ||||||
| Current Ratio | 4.36x | 4.50x | 4.52x | 5.52x | 7.60x | 6.05x |
| Quick Ratio | 4.36x | 4.50x | 4.52x | 5.52x | 7.60x | 6.05x |
| Leverage | ||||||
| Debt/Equity | 0.16x | 0.12x | 0.02x | 0.18x | 0.14x | 0.04x |
YoY = year-over-year change. Source: FMP..